enGene Holdings (ENGN)

• Market cap: $218M
• 1 day: -4.46%
• 5 days: -8.55%
• 1 month: -26.71%
• 3 months: -39.38%
• 6 months: -34.25%
• Year to date: -39.38%
• 1 year: -74.66%
• 5 years: -78.60%
• 10 years: -91.69%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

21% more capital invested

Capital invested by funds: $228M [Q3] → $275M (+$47M) [Q4]

13% more funds holding

Funds holding: 30 [Q3] → 34 (+4) [Q4]

3.47% more ownership

Funds ownership: 77.55% [Q3] → 81.02% (+3.47%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $7 64% upside
• Avg. target: $23 437% upside
• High target: $34 694% upside

4 analyst ratings

• positive: 3 75%
• neutral: 1 25%
• negative: 0 0%

Morgan Stanley Jeffrey Hung 33% 1-year accuracy 9 / 27 met price target	694% upside $34	Overweight Maintained	11 Mar 2025
HC Wainwright & Co. Andres Maldonado 18% 1-year accuracy 9 / 50 met price target	484% upside $25	Buy Reiterated	11 Mar 2025
Piper Sandler Allison Bratzel 27% 1-year accuracy 3 / 11 met price target	507% upside $26	Overweight Initiated	18 Feb 2025
UBS Colin Bristow 43% 1-year accuracy 6 / 14 met price target	64% upside $7	Neutral Downgraded	14 Feb 2025